New therapy eliminates gum disease bacterium while preserving beneficial oral microbes

Researchers at Nagoya University in Japan have developed a groundbreaking therapy for periodontitis that specifically targets and destroys harmful gum disease bacteria without harming essential oral microbes. The treatment, called near-infrared photo-antibacterial targeting therapy (NIR-PAT²), uses an antibody-dye compound that binds to Porphyromonas gingivalis (P. gingivalis), a key pathogen responsible for gum disease and bone loss.

Unlike traditional treatments like antibiotics and photodynamic therapy, NIR-PAT² preserves the beneficial oral microbes that maintain a healthy oral environment. In tests on human cell cultures and mice, the therapy effectively eliminated P. gingivalis while leaving other bacteria and healthy gum cells untouched. Crucially, it also reduced alveolar bone loss in mice models of periodontitis and improved oral microbiota by preserving beneficial Streptococcus populations.

Unlike antibiotics and traditional light therapy, NIR-PAT² selectively targets P. gingivalis, offering a promising, targeted approach to treating periodontitis while maintaining overall oral health.